Hra Pharma company information, Employees & Contact Information

Mayne hit by 'misleading' drug safety claims from the FDA ahead of $430M buyout Fierce Pharma

Perrigo Completes Divestment of HRA Pharma Rare Diseases Business PR Newswire

Perrigo to buy HRA Pharma in $2.1 bln deal to expand self-care portfolio Reuters

Esteve to acquire Perrigo’s HRA pharma rare diseases business The Pharma Letter

Over-the-counter birth control pills are available worldwide. The U.S. may be next NPR

Perrigo to divest rare diseases unit to Spain's Esteve for up to €275M FirstWord Pharma

F.D.A. to Weigh Over-the-Counter Sale of Contraceptive Pills (Published 2022) The New York Times

U.S. women still can’t get birth control pills over the counter. Inside one company's 9-year struggle to change that Fortune

HRA Pharma & Celnova Pharma partner to launch medicines in South America for adrenocortical carcinoma The Cancer Letter

HRA Pharma CEO steps down Medical Marketing and Media

Clifford Chance advises on ESTEVE binding offer for the acquisition of HRA Pharma Rare Diseases Iberian Lawyer

HRA Pharma and Afaxys Join Forces on Emergency Contraceptive ella(R) in the USA GlobeNewswire

Perrigo to shed rare disease affiliate in $294M deal Crain's Grand Rapids Business

Perrigo dishes out $2.1B for HRA Pharma, a big step on its quest to become self-care heavyweight Fierce Pharma

Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million PR Newswire

Drugmaker Seeks FDA Approval of First Over-The-Counter Birth Control Pill NBC4 Washington

HRA Pharma applies for approval of OTC birth control pill Medical Marketing and Media

HRA Pharma debuts one-stop hub for rare disease Cushing's syndrome aimed at physicians Fierce Pharma

Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill PR Newswire

PERRIGO COMPLETES THE ACQUISITION OF HRA PHARMA PR Newswire

The top 10 biopharma M&A deals in 2021 Fierce Pharma

Perrigo To Acquire Consumer Self-Care Company, HRA Pharma Moody on the Market

FDA to consider application for first over-the-counter birth control pill Axios

A fairy-tale princess meets reality in HRA Pharma's new ellaOne campaign Fierce Pharma

Perrigo plots hundreds of job cuts as it embarks on restructuring initiative Fierce Pharma

AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases PR Newswire

Astorg and Goldman Sachs Asset Management to sell HRA Pharma to Perrigo in EUR1.8bn deal Private Equity Wire

HRA Pharma launches ellaOne® website for pharmacists European Pharmaceutical Review

Amid reorg, Perrigo picks Bayer alum as inaugural brand and digital chief Fierce Pharma

HRA Pharma Doesn’t Have Stock: How to Invest in Opill Maker Market Realist

Perrigo : to Acquire Leading Consumer Self-Care Company, HRA Pharma MarketScreener

With nonprescription nod for Perrigo's Opill, the age of the over-the-counter birth control pill arrives in the US Fierce Pharma

Perrigo's generics split is back on the docket, thanks to $1.55B Altaris offer Fierce Pharma

Perrigo's over-the-counter birth control launch takes flight in the US Fierce Pharma

Amazon breaks into drug sales with Perrigo's store-brand OTC medications Fierce Pharma

Gilead, Sanofi, GSK and more to pay for employees' abortion-related travel costs after Roe ruling Fierce Pharma

Drugmaker seeks approval for first nonprescription birth control pill in U.S. The Washington Post

After Roe ruling, Bayer enlists lobbyists to fight for contraceptive access Fierce Pharma

FDA moves to boost access to overdose reversal med with preliminary over-the-counter endorsement Fierce Pharma

Takeda taps a doctor turned patient—and spread-the-word artist—for rare disease awareness campaign Fierce Pharma

The first steps toward over-the-counter birth control in the US are finally underway vox.com

In legal battle over abortion pill, conflicting rulings leave future access up in the air Fierce Pharma

With ominous FDA talks, ObsEva scraps lead women's health drug, plots layoffs in major restructuring Fierce Pharma

Conservative group sues FDA in bid to overturn decades-old approval for abortion pill Fierce Pharma

A third of women too embarrassed to talk to pharmacist about morning after pill The Pharmaceutical Journal

HRA Pharma’s former CEO David Wright joins Ceuta Group Pharmacy Business

HRA launches ‘fairytale’ digital ad campaign for ellaOne brand PMLiVE

Make Emergency Contraceptives GSL In The UK, Urge HRA Pharma And The British Pregnancy Advisory Service Citeline News & Insights

USA Triathlon Partners with Compeed as Exclusive Blister Care Partner Through 2023 USA Triathlon

New Warning: Morning-After Pill Doesn’t Work for Women Over 176 Pounds Mother Jones

HRA Pharma CEO resigns; chief commercial officer Martyn Hilton is asked to step up as interim boss Pharmacy Business

Emergency contraceptive pill thought to be ineffective in women over 75kgs Australian Broadcasting Corporation